New York State Common Retirement Fund
ZVRA icon

New York State Common Retirement Fund’s Zevra Therapeutics ZVRA Stock Holding History

New York State Common Retirement Fund’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$357K Buy
38,349
+28,242
+279% +$255K ﹤0.01% 2032
2025
Q4 		$90.6K Hold
10,107
– – ﹤0.01% 2654
2025
Q3 		$96.1K Hold
10,107
– – ﹤0.01% 2640
2025
Q2 		$89K Hold
10,107
– – ﹤0.01% 2753
2025
Q1 		$75.7K Hold
10,107
– – ﹤0.01% 2639
2024
Q4 		$84.3K Hold
10,107
– – ﹤0.01% 2663
2024
Q3 		$70.1K Buy
10,107
+7,800
+338% +$52.9K ﹤0.01% 2752
2024
Q2 		$11.3K Buy
2,307
+16
+0.7% +$76 ﹤0.01% 3237
2024
Q1 		$13.3K Sell
2,291
-14,700
-87% -$90.4K ﹤0.01% 3175
2023
Q4 		$111K Sell
16,991
-77
-0.5% -$360 ﹤0.01% 2710
2023
Q3 		$82.3K Buy
17,068
+368
+2% +$1.84K ﹤0.01% 2816
2023
Q2 		$85.2K Buy
+16,700
New +$90K ﹤0.01% 2976
2022
Q3 		– Sell
-181
Closed -$1K – 3470
2022
Q2 		$1K Sell
181
-13,171
-99% -$60K ﹤0.01% 3424
2022
Q1 		$67K Hold
13,352
– – ﹤0.01% 3107
2021
Q4 		$116K Sell
13,352
-50
-0.4% -$446 ﹤0.01% 3038
2021
Q3 		$125K Sell
13,402
-11,098
-45% -$112K ﹤0.01% 3070
2021
Q2 		$314K Buy
+24,500
New +$263K ﹤0.01% 2823

Other funds holding ZVRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

New York State Common Retirement Fund's ZVRA Position: Q1 2026 in Review

New York State Common Retirement Fund increased its Zevra Therapeutics (ZVRA) stake by 279% in Q1 2026, buying an estimated $255K and bringing the position to 38,349 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #2032.

New York State Common Retirement Fund first reported a position in ZVRA in Q2 2021 and has held it in 17 quarters since. 148 funds tracked by Wall St. Rank hold ZVRA as of Q1 2026.

  • New York State Common Retirement Fund held 38,349 shares of Zevra Therapeutics worth $357K as of Q1 2026.
  • New York State Common Retirement Fund bought 28,242 Zevra Therapeutics shares in Q1 2026, an estimated $255K.
  • Zevra Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #2032 holding.
  • New York State Common Retirement Fund first reported a position in Zevra Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • 148 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.